Filters

Influenza A H1N1 antibody (FITC conjugated)

Influenza A H1N1 antibody (FITC conjugated) size: 1 vial 717

Supplier GENWAYS
Price 717
Size 1 vial
Storage temperaturestore cold
Expiry date1 y
Category ELISAs, recombinant proteins, vectors and reagents for laboratory use, research antibodies
Properties FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, When excited at 488 nanometers, genways FITC is highly sensitive to pH extremes, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, This genways Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS
ConjugationAnti-FITC Antibody
Description Influenza is an , The cough, These symptoms typically begin two days after exposure to the virus and most last less than a week, and , but these are not common in adults, however, may last for more than two weeks, peptides and antibodies detect a virus commonly known as ", there may be ,  ,  ,  ,  ,  ,  ,  ,  , In children, Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, Symptoms can be mild to severe, The most common , and , caused by an , coughing, feeling tired, fever, flu", headache, infectious disease , influenza virus, muscle pains, nausea , runny nose, sore throat, symptoms include a high , the , vomiting
French translationanticorps
Gene targetInfluenza A H1N1 conjugated)
Short nameInfluenza A H1N1 antibody (FITC conjugated)
Technique Fluorescein, FITC
LabelFITC
Species Influenza, Influenza
Alternative nameInfluenza A H1N1 (Antibody to) (fluorecein coupled)
Alternative techniqueantibodies

Subscribe to our Newsletter